{
    "nctId": "NCT04461977",
    "briefTitle": "Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer",
    "officialTitle": "Acupuncture for Treatment of Peripheral Neuropathy Induced by Neoadjuvant or Adjuvant Paclitaxel in Early Stage Breast Cancer: a Sham Controlled, Randomized Study",
    "overallStatus": "COMPLETED",
    "conditions": "Peripheral Neuropathy Due to Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "The change the effects of neuropathic pain syndromes management from baseline",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>= 18 years old.\n* Agreed to sign the Informed Consent Term\n* ECOG 0-1\n* Breast cancer stages I, II and III.\n* Received adjuvant or neoadjuvant chemotherapy containing weekly paclitaxel 80 mg/m2.\n* Peripheral sensory neuropathy grade 2 and 3 by the \"Common Terminology Criteria for Adverse Events\" (CTCAE) v5.0\n\nExclusion Criteria:\n\n* Previous history of peripheral neuropathy due to other comorbidities.\n* Prior treatment with chemotherapy for cancer other than breast cancer.\n* Use of medications to treat peripheral neuropathy.\n* Metastatic disease.\n* Presence of lymphedema of any degree.\n* History of coagulopathy or full anticoagulation.\n* Previous acupuncture treatment for any indication within the last 90 days.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}